Part 7/11:
China’s vast population provides an unparalleled resource of real-world data, vital for drug discovery and personalized medicine. The country has also taken significant strides in digitizing health data, enabling faster research and development cycles. With an aging population, demand for new therapies—especially in oncology and chronic diseases—is expected to surge, further fueling innovation and clinical trials.
Expanding patient data, combined with China's investment in digital health infrastructure, positions the country as a major player in the global pharmaceutical future.